FDA Orange Book
Is there a generic for Qamzova?
Qamzova contains meloxicam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Qamzova (meloxicam). The Orange Book shows its last listed patent expires July 19, 2040.
Run it in Rivvi
Map Qamzova and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Qamzova products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 30MG/ML (30MG/ML) | Marketed (Rx) | None | 0 | None |
NDA 217593, held by NANJING DELOVA BIOTECH CO LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Qamzova patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 12059423 | July 19, 2040 | Drug substance, Drug product | None | 217593 |
Qamzova NDC codes
Questions
Is there a generic for Qamzova?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Qamzova (meloxicam). The Orange Book shows its last listed patent expires July 19, 2040.
What is the generic name for Qamzova?
The active ingredient in Qamzova is meloxicam, per the FDA Orange Book.
When does the Qamzova patent expire?
The last patent listed for Qamzova in the Orange Book expires July 19, 2040. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.